|
AU2008201709A1
|
|
Peptide-based Multimeric Targeted Contrast Agents
|
|
CN101528124A
|
|
Methods for lymph system imaging
|
|
AU2007227278A1
|
|
SIP receptor modulating compounds and use thereof
|
|
US2008027036A1
|
|
S1P receptor modulating compounds and use thereof
|
|
US2007293656A1
|
|
Collagen binding peptides
|
|
WO2007047608A2
|
|
Fibrin targeted therapeutics
|
|
US2007173487A1
|
|
S1P receptor modulating compounds and use thereof
|
|
AU2006202989A1
|
|
Systems and Methods for Targeted Magnetic Resonance Imaging of the Vascular System
|
|
EP1848465A2
|
|
Steady state perfusion methods
|
|
AU2005202428A1
|
|
Targeting Multimeric Imaging Agents Through Multilocus Binding
|
|
EP1675624A1
|
|
Stationary target mr imaging
|
|
BRPI0410635A
|
|
optically pure enriched isomers of chelating binders and contrast agents
|
|
CA2539215A1
|
|
Diagnostic imaging contrast agents with extended blood retention
|
